BRIEF published on 11/22/2024 at 18:05, 1 year 10 months ago MedinCell: Update of share capital and voting rights Share Capital Voting Rights Euronext Actions Medincell
PRESS RELEASE published on 11/22/2024 at 18:00, 1 year 10 months ago Informations privilégiées / Autres communiqués Euronext informe sur les droits de vote et le capital social de MedinCell. MedinCell, biopharmaceutique en France, développe des médicaments injectables à action prolongée Droits De Vote Euronext Capital Social Biopharmaceutique Medincell
BRIEF published on 11/06/2024 at 13:47, 1 year 10 months ago Medincell : Revenus 2024 à la hausse et avancée clinique significative Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
BRIEF published on 11/06/2024 at 13:47, 1 year 10 months ago Medincell: 2024 revenues on the rise and significant clinical progress Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
PRESS RELEASE published on 11/06/2024 at 13:42, 1 year 10 months ago Informations privilégiées / Autres communiqués Medincell relève ses prévisions de revenus UZEDY® de 25% et franchit une étape majeure dans l'essai clinique de l'Olanzapine LAI. Tous les détails dans le communiqué de presse de Teva pour le troisième trimestre 2024 Revenus Essai Clinique Medincell Teva UZEDY
PRESS RELEASE published on 11/06/2024 at 13:42, 1 year 10 months ago Inside Information / Other news releases Medincell achieves 25% increase in 2024 UZEDY® revenue outlook reaching $100M and key milestone in Olanzapine LAI Phase 3 clinical trials. Teva Pharmaceuticals shares Q3 results Revenue Clinical Trials Medincell Teva Pharmaceuticals UZEDY
BRIEF published on 10/01/2024 at 15:47, 1 year 11 months ago Franchissement de seuil par Mirova dans MEDINCELL Capital Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 10/01/2024 at 15:47, 1 year 11 months ago Threshold crossing by Mirova in MEDINCELL Capital Actions Threshold Crossing Medincell Mirova
PRESS RELEASE published on 10/01/2024 at 15:42, 1 year 11 months ago Franchissement de seuil Déclaration de franchissement de seuil par Mirova pour le compte de fonds gérés, détenant 7,07% du capital et 5,01% des droits de vote de MEDINCELL Acquisition Franchissement De Seuil AMF Medincell Mirova
BRIEF published on 09/24/2024 at 11:54, 2 years ago Teva et Medincell Présentent des Résultats Prometteurs sur l'Olanzapine LAI pour la Schizophrénie Schizophrénie Essai Clinique Medincell Teva Olanzapine LAI
Published on 09/26/2026 at 01:00, 2 days ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 3 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 7 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 10 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 8 hours 15 minutes ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 9 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 9 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 10 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 17 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 7 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 7 hours ago Availability of the 2026 half-year financial report
